Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 3,888 | 4,026 | 3,016 | 32,858 | 1,954 |
| Operating Income | -3,888 | -4,026 | -3,016 | -32,858 | -1,954 |
| Interest Expense | 1 | 6 | 26 | 655 | 1,711 |
| Other Income | -316 | 5,105 | 11,129 | 1,767 | -365 |
| Pre-tax Income | -4,205 | 1,073 | 8,087 | -31,746 | -4,030 |
| Net Income Continuous | -4,205 | 1,073 | 8,087 | -31,746 | -4,030 |
| Net Income | $-4,205 | $1,073 | $8,087 | $-31,746 | $-4,030 |
| EPS Basic Total Ops | -194.30 | 1,320.09 | 314.84 | -2,691.16 | -1,086.96 |
| EPS Basic Continuous Ops | -194.58 | 1,136.73 | 501.01 | -2,694.48 | -1,088.65 |
| EPS Diluted Total Ops | -194.30 | 1,300.75 | 314.84 | -3,073.46 | -1,086.96 |
| EPS Diluted Continuous Ops | -194.58 | 1,102.91 | 500.72 | -2,648.89 | -1,088.65 |
| EBITDA(a) | $-3,887 | $-4,026 | $-3,016 | $-32,857 | $-1,953 |